Epidemiology & Risk Factors

  • Demographics: Most common benign breast mass in premenopausal women (peak incidence: 35–50 yrs; perimenopausal).
  • Etiology: Distension of terminal duct lobular units (TDLUs) secondary to fluid accumulation.
  • Risk Factors:
    • Endogenous hormonal fluctuations (estrogen-predominant states).
    • Postmenopausal hormone replacement therapy (HRT).
    • Caffeine intake (controversial, but historically noted).

Clinical Features

  • History (Hx):
    • Acute onset of single or multiple breast masses.
    • Cyclic tenderness: Pain and size fluctuate with the menstrual cycle (typically enlarges and becomes more tender during the premenstrual/luteal phase).
  • Physical Exam (PE):
    • Palpation: Well-circumscribed, smooth, firm-to-elastic, mobile, compressible/fluctuant mass.
    • Negative for skin dimpling, nipple retraction, or fixed axillary lymphadenopathy.

Diagnosis

  • Initial/Screening Strategy (by age):
    • Age < 30 yrs: Targeted Breast Ultrasound (US) (initial imaging modality of choice due to dense breast tissue).
    • Age ≥ 30 yrs: Diagnostic Mammography + Breast US.
  • Ultrasonographic Classification:
    • Simple Cyst:
      • Anechoic (echo-free lumen).
      • Posterior acoustic enhancement.
      • Well-circumscribed with thin, imperceptible margins/walls.
      • Absence of internal echoes, septations, or solid components.
    • Complicated Cyst:
      • Internal low-level echoes/debris (fluid-debris levels, “debris-filled”).
      • Thin walls; no vascularity on Doppler.
    • Complex (Solid & Cystic) Cyst:
      • Thick walls, thick internal septations (> 0.5 mm).
      • Internal solid components or intra-cystic vascularity on Doppler (suspicious for malignancy).
  • Confirmatory / Tissue Sampling:
    • Fine-Needle Aspiration (FNA): Both diagnostic and therapeutic for symptomatic or indeterminate fluid-filled lesions.
    • Core Needle Biopsy (CNB): Indicated for complex cystic masses, persistent mass post-aspiration, or bloody aspirate.

Differential Diagnostics

  • Fibroadenoma:
    • Diff by solid, hypoechoic, rubbery, “slip-and-slide” mobile mass; non-fluctuant; peak age 15–35 yrs; does not disappear with aspiration.
  • Fibrocystic Changes:
    • Diff by diffuse, bilateral, multifocal “lumpy-bumpy” breast tissue rather than a solitary, dominant, well-defined discrete cyst.
  • Invasive Breast Carcinoma:
    • Diff by hard, fixed, immobile mass with irregular/spiculated borders, posterior acoustic shadowing on US, and microcalcifications on mammogram.
  • Fat Necrosis:
    • Diff by positive history of local trauma, breast surgery, or radiation; presents as firm, irregular mass; shows lipid droplets and foamy macrophages on histology.
  • Breast Abscess:
    • Diff by overt infectious signs (fever, localized warmth, severe erythema, fluctuance), typically occurring in lactating women secondary to untreated mastitis.
  • Intraductal Papilloma:
    • Diff by spontaneous, unilateral serous or bloody nipple discharge without a large palpable mass (located subareolarly).

Management

  • 1. Simple Cysts:
    • Asymptomatic: Reassurance and routine age-appropriate screening (no intervention required).
    • Symptomatic / Painful: Therapeutic FNA.
      • Clear/Straw-colored fluid + Complete resolution of mass: Discard fluid; clinical follow-up in 2–4 months to verify non-recurrence.
      • Bloody fluid OR Incomplete mass collapse: Send fluid for cytology + perform Core Needle Biopsy (CNB) or excisional biopsy.
  • 2. Complicated Cysts:
    • Asymptomatic / Low Risk (BI-RADS 3): Short-interval follow-up with serial diagnostic US at 6, 12, and 24 months OR elective FNA.
    • Symptomatic: Aspiration; send for cytology if bloody.
  • 3. Complex / Solid-Cystic Cysts (BI-RADS 4/5):
    • First-line: Core Needle Biopsy (CNB) under US guidance (rules out papillary lesions, ductal carcinoma in situ [DCIS], or invasive carcinoma).
  • 4. Recurrent Cysts:
    • Repeat FNA if symptomatic; if cyst recurs repeatedly (> 2–3 times) at the same focal site -> Surgical excision to rule out malignancy.

Complications

  • Secondary Infection / Abscess: Bacterial inoculation (spontaneous or post-aspiration).
  • Cyst Rupture: Release of irritant fluid leading to localized aseptic inflammation, sharp focal pain, and surrounding fat necrosis.
  • Delayed Malignancy Diagnosis: Missed intracystic papillary carcinoma or necrotic malignant tumor if complex features are overlooked.